KARABELAS ARGERIS N Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$3.82M
Insider Sells Quantity
24
Insider Sells Sum
$137.92M

Insider Activity of KARABELAS ARGERIS N

Biography of KARABELAS ARGERIS N

No biography is available at this moment.

2024-10-01SaleREGENXBIO Inc.
RGNX
director
10,000
0.0191%
$10.11$101,052-15.28%
2024-09-03SaleREGENXBIO Inc.
RGNX
director
10,000
0.0206%
$11.56$115,588-23.72%
2024-08-01SaleREGENXBIO Inc.
RGNX
director
10,100
0.0208%
$13.51$136,454-34.26%
2024-07-29SaleREGENXBIO Inc.
RGNX
director
11,000
0.0234%
$15.04$165,495-38.75%
2024-07-01SaleREGENXBIO Inc.
RGNX
director
10,000
0.0199%
$11.27$112,691-16.98%
2016-08-11PurchaseBausch Health Companies Inc.
BHC
director
8,000
0.0023%
$24.65$197,200-37.34%
2015-02-23PurchaseRocket Pharmaceuticals, Inc.
RCKT
603,832
7.7359%
$6.00$3.62M+28.2%
2010-03-12SaleVanda Pharmaceuticals Inc.
VNDA
director
400,000
1.4209%
$11.80$4.72M-36.16%
2009-12-15SaleVanda Pharmaceuticals Inc.
VNDA
director
197,848
0.7357%
$11.03$2.18M-26.18%
2009-12-14SaleVanda Pharmaceuticals Inc.
VNDA
director
260,000
0.9703%
$11.14$2.9M-26.65%
2009-12-09SaleVanda Pharmaceuticals Inc.
VNDA
director
214,400
0.8104%
$11.57$2.48M-28.46%
2009-12-08SaleVanda Pharmaceuticals Inc.
VNDA
director
52,752
0.1993%
$11.30$596,098-26.78%
2009-12-07SaleVanda Pharmaceuticals Inc.
VNDA
director
200,000
0.7442%
$11.57$2.31M-29.45%
2009-12-04SaleVanda Pharmaceuticals Inc.
VNDA
director
200,000
0.7378%
$11.70$2.34M-30.75%
2009-10-13SaleVanda Pharmaceuticals Inc.
VNDA
director
475,000
2.0147%
$12.65$6.01M-9.1%
2007-02-23SaleVanda Pharmaceuticals Inc.
VNDA
director
768,260
3.0655%
$26.02$19.99M-37.62%
2007-02-22SaleVanda Pharmaceuticals Inc.
VNDA
director
145,200
0.5743%
$26.82$3.89M-39.67%
2007-02-21SaleVanda Pharmaceuticals Inc.
VNDA
director
474,000
1.8684%
$26.74$12.67M-39.28%
2007-02-20SaleVanda Pharmaceuticals Inc.
VNDA
director
400,000
1.5757%
$27.37$10.95M-40.66%
2006-12-12SaleVanda Pharmaceuticals Inc.
VNDA
Chairman of the Board
848,300
5.3245%
$25.18$21.36M-19.11%
Total: 26
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.